Doctor Ricky Turgeon

Doctor Ricky Turgeon

University of British Columbia, Vancouver (Canada)

Member of:

Dr. Turgeon’s research focuses on integrating high-quality observational studies and meta-analyses of clinical studies to guide the creation and evaluation of decision support tools and other knowledge translation strategies to ensure that pharmacotherapy for cardiovascular disease align with patient goals, preferences and values. His research is centered on implementation science, with a focus on antithrombotic agents, lipid-lowering therapies, pharmacotherapy for heart failure, and on the cardiovascular safety of medications.

Presentations Articles

Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic

Event: ESC Congress 2023

Topic: Advanced Clinical Practice

Session: Innovative models of cardiovascular care

Access

Comparing dual antiplatelet therapy strategies post-acute coronary syndrome: network meta-analysis

Event: ESC Congress 2022

Topic: Antiplatelet Drugs

Session: Short and long-term antiplatelet therapy in clinical practice

Access

Doctor Ricky Turgeon

Biography

Contributor content

Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic

Comparing dual antiplatelet therapy strategies post-acute coronary syndrome: network meta-analysis

ESC 365 is supported by